AR043252A1 - Formulaciones de glucocorticoesteroides para tratar angiogenia ocular patologica - Google Patents
Formulaciones de glucocorticoesteroides para tratar angiogenia ocular patologicaInfo
- Publication number
- AR043252A1 AR043252A1 ARP040100545A ARP040100545A AR043252A1 AR 043252 A1 AR043252 A1 AR 043252A1 AR P040100545 A ARP040100545 A AR P040100545A AR P040100545 A ARP040100545 A AR P040100545A AR 043252 A1 AR043252 A1 AR 043252A1
- Authority
- AR
- Argentina
- Prior art keywords
- formulations
- glucocorticoesteroids
- angiogenia
- treat pathological
- pathological eye
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Formulaciones de glucocorticoesteroides solos y en combinación con anecortave acetato, útiles para la prevención y el tratamiento de angiogenia ocular patológica y edema asociado.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44894403P | 2003-02-20 | 2003-02-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR043252A1 true AR043252A1 (es) | 2005-07-20 |
Family
ID=32908675
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP040100545A AR043252A1 (es) | 2003-02-20 | 2004-02-20 | Formulaciones de glucocorticoesteroides para tratar angiogenia ocular patologica |
Country Status (16)
Country | Link |
---|---|
US (2) | US20040167109A1 (es) |
EP (1) | EP1594511A2 (es) |
JP (2) | JP2006518383A (es) |
KR (1) | KR20050102653A (es) |
CN (1) | CN100431544C (es) |
AR (1) | AR043252A1 (es) |
AU (1) | AU2004212900A1 (es) |
BR (1) | BRPI0407742A (es) |
CA (1) | CA2516790A1 (es) |
MX (1) | MXPA05008396A (es) |
PL (1) | PL378209A1 (es) |
RU (1) | RU2005129278A (es) |
TW (1) | TW200507858A (es) |
UY (1) | UY28203A1 (es) |
WO (1) | WO2004073608A2 (es) |
ZA (1) | ZA200505990B (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007506678A (ja) * | 2003-09-23 | 2007-03-22 | アルコン,インコーポレイテッド | 注入のためのトリアムシノロンアセトアニドおよび酢酸アネコルタブの処方物 |
US7257366B2 (en) * | 2003-11-26 | 2007-08-14 | Osmosis Llc | System and method for teaching a new language |
KR20080059175A (ko) * | 2005-09-07 | 2008-06-26 | 사우스웨스트 리서치 인스티튜트 | 방출속도가 향상된 생분해성 미립자 약제학적 제제 |
US9693967B2 (en) | 2005-09-07 | 2017-07-04 | Southwest Research Institute | Biodegradable microparticle pharmaceutical formulations exhibiting improved released rates |
US20070149616A1 (en) * | 2005-12-22 | 2007-06-28 | Alcon Manufacturing, Ltd. | C3-Convertase Inhibitors for the Prevention and Treatment of Age-Related Macular Degeneration in Patients With At Risk Variants Of Complement Factor H |
US20070173538A1 (en) * | 2005-12-23 | 2007-07-26 | Alcon, Inc. | PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE |
GB0625844D0 (en) * | 2006-12-22 | 2007-02-07 | Daniolabs Ltd | The treatment of macular degeneration |
CA2693888A1 (en) * | 2007-07-20 | 2009-01-29 | Alcon, Inc. | Pharmaceutical formulation for delivery of receptor tyrosine kinase inhibiting (rtki) compounds to the eye |
EP2977084B1 (en) * | 2010-05-10 | 2017-07-05 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and compositions for the treatment of fluid accumulation in and/ or under the retina |
WO2015191795A1 (en) * | 2014-06-12 | 2015-12-17 | The Research Foundation For The State University Of New York | Methods of using gap junctions as therapeutic targets for the treatment of degenerative disorders of the retina |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4975537A (en) * | 1985-10-23 | 1990-12-04 | The Upjohn Company | Δ9(11) -angiostatic steroids |
US4686214A (en) * | 1985-10-30 | 1987-08-11 | Alcon Laboratories, Inc. | Anti-inflammatory compounds for ophthalmic use |
US4771042A (en) * | 1985-11-25 | 1988-09-13 | The Upjohn Company | Inhibition of angiogenesis involving the coadministration of steroids with heparin or heparin fragments |
US4853224A (en) * | 1987-12-22 | 1989-08-01 | Visionex | Biodegradable ocular implants |
US5371078A (en) * | 1988-10-31 | 1994-12-06 | Alcon Laboratories, Inc. | Angiostatic steroids and methods and compositions for controlling ocular hypertension |
US5164188A (en) * | 1989-11-22 | 1992-11-17 | Visionex, Inc. | Biodegradable ocular implants |
US5378475A (en) * | 1991-02-21 | 1995-01-03 | University Of Kentucky Research Foundation | Sustained release drug delivery devices |
US5770592A (en) * | 1991-11-22 | 1998-06-23 | Alcon Laboratories, Inc. | Prevention and treatment of ocular neovascularization using angiostatic steroids |
AU684115B2 (en) * | 1993-12-27 | 1997-12-04 | Mitsubishi Chemical Corporation | Ophthalmic suspension containing diflupredonate |
US5646136A (en) * | 1994-01-04 | 1997-07-08 | Duke University | Methods of inhibiting angiogenesis and tumor growth, and treating ophthalmologic conditions with angiostatic and therapeutic steroids |
US5516522A (en) * | 1994-03-14 | 1996-05-14 | Board Of Supervisors Of Louisiana State University | Biodegradable porous device for long-term drug delivery with constant rate release and method of making the same |
US5869079A (en) * | 1995-06-02 | 1999-02-09 | Oculex Pharmaceuticals, Inc. | Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
US5773019A (en) * | 1995-09-27 | 1998-06-30 | The University Of Kentucky Research Foundation | Implantable controlled release device to deliver drugs directly to an internal portion of the body |
US5736152A (en) * | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
US6011023A (en) * | 1997-08-27 | 2000-01-04 | Alcon Laboratories, Inc. | Angiostatic steroids |
CA2383572C (en) * | 1999-10-21 | 2007-12-11 | Alcon Universal Ltd. | Sub-tenon drug delivery |
US6416777B1 (en) * | 1999-10-21 | 2002-07-09 | Alcon Universal Ltd. | Ophthalmic drug delivery device |
JP4837861B2 (ja) * | 1999-10-21 | 2011-12-14 | アルコン,インコーポレイティド | ドラッグデリバリ製剤 |
WO2004012742A1 (en) * | 2002-08-05 | 2004-02-12 | Alcon, Inc. | Use of anecortave acetate for the protection of visual acuity in patients with age related macular degeneration |
-
2004
- 2004-02-05 CN CNB2004800043514A patent/CN100431544C/zh not_active Expired - Fee Related
- 2004-02-05 RU RU2005129278/14A patent/RU2005129278A/ru not_active Application Discontinuation
- 2004-02-05 KR KR1020057015189A patent/KR20050102653A/ko not_active Application Discontinuation
- 2004-02-05 AU AU2004212900A patent/AU2004212900A1/en not_active Abandoned
- 2004-02-05 PL PL378209A patent/PL378209A1/pl unknown
- 2004-02-05 MX MXPA05008396A patent/MXPA05008396A/es unknown
- 2004-02-05 BR BRPI0407742-3A patent/BRPI0407742A/pt not_active IP Right Cessation
- 2004-02-05 ZA ZA200505990A patent/ZA200505990B/xx unknown
- 2004-02-05 JP JP2006503391A patent/JP2006518383A/ja active Pending
- 2004-02-05 EP EP04708663A patent/EP1594511A2/en not_active Withdrawn
- 2004-02-05 WO PCT/US2004/003515 patent/WO2004073608A2/en active Application Filing
- 2004-02-05 US US10/772,963 patent/US20040167109A1/en not_active Abandoned
- 2004-02-05 CA CA002516790A patent/CA2516790A1/en not_active Abandoned
- 2004-02-05 US US10/545,053 patent/US20060074061A1/en not_active Abandoned
- 2004-02-19 TW TW093104085A patent/TW200507858A/zh unknown
- 2004-02-19 UY UY28203A patent/UY28203A1/es not_active Application Discontinuation
- 2004-02-20 AR ARP040100545A patent/AR043252A1/es not_active Application Discontinuation
-
2006
- 2006-12-01 JP JP2006326249A patent/JP2007056041A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
RU2005129278A (ru) | 2006-01-27 |
ZA200505990B (en) | 2006-12-27 |
JP2006518383A (ja) | 2006-08-10 |
WO2004073608A2 (en) | 2004-09-02 |
EP1594511A2 (en) | 2005-11-16 |
KR20050102653A (ko) | 2005-10-26 |
BRPI0407742A (pt) | 2006-02-14 |
PL378209A1 (pl) | 2006-03-20 |
TW200507858A (en) | 2005-03-01 |
CN1750829A (zh) | 2006-03-22 |
AU2004212900A1 (en) | 2004-09-02 |
UY28203A1 (es) | 2004-08-31 |
CN100431544C (zh) | 2008-11-12 |
WO2004073608A3 (en) | 2005-03-24 |
JP2007056041A (ja) | 2007-03-08 |
US20060074061A1 (en) | 2006-04-06 |
US20040167109A1 (en) | 2004-08-26 |
CA2516790A1 (en) | 2004-09-02 |
MXPA05008396A (es) | 2006-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006015259A3 (en) | Compounds and compositions as modulators of steroid hormone nuclear receptors | |
BRPI0510094A (pt) | uso de flibanserina no tratamento pré-menstrual e outros distúrbios sexuais femininos | |
MX2011013060A (es) | Formulaciones oftalmicas, metodos de preparacion y metodos para utilizarlas. | |
MX2009012645A (es) | Formulaciones y metodos para tratar el ojo seco. | |
WO2005079143A3 (en) | Topical formulations for the treatment of skin conditions | |
CA2711696C (en) | Therapeutic compositions for treatment of ocular inflammatory disorders | |
WO2004080413A3 (en) | Uses and formulations for transdermal or transmucosal application of active agents | |
MX2007016462A (es) | Composiciones topicas para tratar la piel. | |
MXPA05012784A (es) | Lipidos oxidados y usos de los mismos en el tratamiento de enfermedades y desordenes inflamatorios. | |
BRPI0518228A (pt) | inibidores de cinesina mitótica e métodos de uso destes | |
MY157661A (en) | Bendamustine pharmaceutical compositions | |
WO2006030439A3 (en) | Compositions and methods for inducing hair growth | |
EA200800337A1 (ru) | Композиция и способ введения офтальмологически активных средств | |
CY1112790T1 (el) | Χρηση μαγιας σεληνιου στην αντιμετωπιση της νοσου αλτσχαιμερ | |
EP2069377A4 (en) | METHOD AND COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES AND SKIN FUNCTIONAL DISORDERS | |
EP3330252A3 (en) | Isoprenyl compounds and methods thereof | |
WO2007067519A3 (en) | The use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions | |
TW200801031A (en) | Steroid nitrooxyderivatives | |
AR043252A1 (es) | Formulaciones de glucocorticoesteroides para tratar angiogenia ocular patologica | |
WO2009009417A3 (en) | Pharmaceutical compositions and methods of preventing, treating, or inhibiting inflammatory diseases, disorders, or conditions of the skin, and diseases, disorders, or conditions associated with collagen depletion | |
CL2008000495A1 (es) | Compuestos derivados de tetrahidro-pirazolo[4,3-c]piridina; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como alergias, inflamacion, dolor, cancer, entreotras. | |
TW200509896A (en) | Analeptic and drug combinations | |
TW200728295A (en) | Benzochromene derivatives | |
WO2005044200A3 (en) | Methods and compositions for treating mcp-1 related pathologies | |
WO2004073607A3 (en) | Use of steroids to treat ocular disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |